NCT06087562View on ClinicalTrials.gov

iPACK Block for Total Knee Arthroplasty

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

September 30, 2024

Study Completion Date

December 30, 2024

Conditions
Knee OsteoarthritisKnee Pain ChronicKnee Disease
Interventions
DRUG

Ropivacaine 0.5% Injectable Solution 20mL

Ultrasound-guided iPACK block with 20mL of 0,5% ropivacaine

DRUG

0,9% normal saline 20mL

Ultrasound-guided placebo block with 20mL of 0,9% normal saline

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER